Synlett 2016; 27(18): 2601-2605
DOI: 10.1055/s-0035-1562523
letter
© Georg Thieme Verlag Stuttgart · New York

A One-Pot Synthesis of Highly Functionalized Indolizines by 1,3-Dipolar Cycloaddition of Azomethine Ylides and Phosphorylated Hydroxyketenimines

Issa Yavari*
a   Department of Chemistry, Tarbiat Modares University, PO Box 14115-175, Tehran, Iran   Email: yavarisa@modares.ac.ir
,
Maryam Naeimabadi
a   Department of Chemistry, Tarbiat Modares University, PO Box 14115-175, Tehran, Iran   Email: yavarisa@modares.ac.ir
,
Reza Hosseinpour
a   Department of Chemistry, Tarbiat Modares University, PO Box 14115-175, Tehran, Iran   Email: yavarisa@modares.ac.ir
,
Mohammad Reza Halvagar
b   Department of Inorganic Chemistry, Chemistry and Chemical Engineering Research Center of Iran, PO Box 14335-186, Tehran, Iran
› Author Affiliations
Further Information

Publication History

Received: 19 May 2016

Accepted after revision: 06 July 2016

Publication Date:
01 August 2016 (online)


Abstract

Alkyl 2-(alkylamino)-3-(quinolin-2-yl)indolizine-1-carboxylates were prepared by1,3-dipolar cycloaddition of azomethine ylides with phosphorylated hydroxyketenimines, generated in situ by a Nef isocyanide–Perkow cascade.

Supporting Information

 
  • References and Notes


    • For reviews, see:
    • 1a Dömling A. Chem. Rev. 2006; 106: 17
    • 1b Váradi A, Palmer CT, Dardashti RN, Majumdar S. Molecules 2016; 21: 19
    • 1c Rotstein BH, Zaretsky S, Rai V, Yudin AK. Chem. Rev. 2014; 114: 8323
  • 2 La Spisa F, Tron GC, El Kaïm L. Synthesis 2014; 46: 829
  • 3 Coffinier D, El Kaïm L, Grimaud L. Org. Lett. 2009; 11: 1825
    • 5a Dyker G. Angew. Chem. Int. Ed. 1999; 38: 1698
    • 5b Colby DA, Bergman RG, Ellman JA. Chem. Rev. 2010; 110: 624
    • 5c Ritleng V, Sirlin C, Pfeffer M. Chem. Rev. 2002; 102: 1731
    • 5d Zhang G, Luo Y, Wang Y, Zhang L. Angew. Chem. Int. Ed. 2011; 50: 4450
    • 6a Lamani M, Prabhu KR. J. Org. Chem. 2011; 76: 7938
    • 6b Yanagisawa S, Ueda K, Taniguchi T, Itami K. Org. Lett. 2008; 10: 4673
    • 6c Bajracharya GB, Daugulis O. Org. Lett. 2008; 10: 4625
    • 6d Sun C.-L, Li H, Yu D.-G, Yu M, Zhou X, Lu X.-Y, Huang K, Zheng S.-F, Li B.-J, Shi Z.-J. Nat. Chem. 2010; 2: 1044
    • 6e Chudasama V, Fitzmaurice RJ, Caddick S. Nat. Chem. 2010; 2: 592
    • 6f Shirakawa E, Itoh K, Higashino T, Hayashi T. J. Am. Chem. Soc. 2010; 132: 15537
    • 6g Liu W, Cao H, Zhang H, Zhang H, Chung KH, He C, Wang H, Kwong FY. Lei A. 2010; 132: 16737
  • 7 Kumar A, Gupta G, Srivastava S. Org. Lett. 2011; 13: 6366
  • 8 Yavari I, Hosseinpour R, Skoulika S. Synlett 2015; 26: 380
  • 9 Yavari I, Hosseinpour R, Pashazadeh R, Ghanbari E, Skoulika S. Tetrahedron 2013; 69: 2462
  • 10 Quinolinylindolizines 5; General Procedure A mixture of 2-methylquinoline (0.286 g, 2 mmol) with pyridine or isoquinoline (4 mmol) and I2 (0.506 g, 2 mmol) in MeCN (4 mL) was warmed to 60 °C for 2 h. (i-Pr)2NEt (0.541 g, 4.2 mmol) and a solution of the appropriate ketenimine 1 (2 mmol) in MeCN (1 mL) were added, and the mixture was kept overnight at 60 °C then placed in a freezer for 24 h. The precipitate was collected by filtration and crystallized [hexane–EtOAc (1:5)]. Ethyl 2-(Cyclohexylamino)-3-quinolin-2-ylindolizine-1-carboxylate (5b) Yellow crystals; yield: 0.52 g (68%); mp 227–229 °C. IR (KBr): 3436, 3105, 2928, 2850, 1696, 1600, 1547, 1502, 1448, 1265, 1194 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.97–1.02 (m, 2 H), 1.11–1.26 (m, 3 H), 1.39–1.42 (m, 1 H), 1.48 (t, J = 7.1 Hz, 3 H), 1.58–1.61 (m, 2 H), 1.86–1.89 (m, 2 H), 2.97–2.03 (m, 1 H), 4.44 (q, J = 7.1 Hz, 2 H), 6.10 (br s, 1 H), 6.78 (t, J = 6.9 Hz, 1 H), 7.17 (t, J = 7.8 Hz, 1 H), 7.51 (t, J = 7.1 Hz, 1 H), 7.72 (t, J = 7.1 Hz, 1 H), 7.80 (d, J = 7.8 Hz, 1 H), 8.08–8.13 (m, 4 H), 9.93 (d, J = 7.0 Hz, 1 H). 13C NMR (125.7 MHz, CDCl3): δ = 14.6 (Me), 24.7 (2 CH2), 25.7 (CH2), 33.7 (2 CH2), 57.1 (CH2O), 59.4 (CH), 94.9 (C), 111.1 (CH), 112.5 (C), 118.0 (C), 122.0 (CH), 124.2 (CH), 124.4 (CH), 125.3 (CH), 125.7 (C), 127.4 (CH), 128.6 (CH), 129.5 (CH), 135.3 (C), 136.1 (CH), 144.8 (CH), 147.3 (C), 152.3 (C), 166.3 (C=O). MS (EI): m/z (%) = 413 (100) [M+], 330 (46), 315 (53), 285 (34), 242 (30), 128 (50), 98 (40), 83 (35), 73 (55). Anal. Calcd for C26H27N3O2 (413.51): C, 75.52; H, 6.58; N, 10.16. Found: C, 75.98; H, 6.64; N, 10.22. X-ray Crystal-Structure Determination of 5b Yellow crystals of compound 5b suitable for single-crystal X-ray diffraction measurements (crystal dimensions: 0.18 × 0.12 × 0.09 mm) were grown by slow evaporation of a solution in EtOH–EtOAc. The unit cell dimensions were determined from 658 reflections. The structure was solved by direct methods and refined by full matrix least-squares calculations based on F2 to a final R1 = 0.0404 and wR2 (all data) = 0.0805, by using SHELXL-2014 and WinGX-2013.3 programs.12 Compound 5b crystallized in the monoclinic system with space group P21/n. A single molecule with molecular formula of C26H27N3O2 was found in the asymmetric unit, giving a total Z = 4 for the unit cell; a = 11.911(2), b = 10.311(2), c = 18.106(4), β = 90.68(3), cell volume V = 2223.5(8)Å3; measurement temperature 293(2) K, measurement range: 2.036 < θ < 24.713; 3767 independent reflections and maximum/minimum residual electron density [e Å3]: 0.136 /–0.13. All nonhydrogen atoms were refined with anisotropic displacement parameters. Hydrogen atoms were placed in ideal positions and refined as riding atoms with relative isotropic displacement parameters. An ORTEP view of the structure is shown in Figure 1. CCDC 1457966 contains the supplementary crystallographic data for compound 5b in this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.
  • 11 Methyl 2-(Cyclohexylamino)-3-quinolin-2-ylpyrrolo[2,1-a]isoquinoline-1-carboxylate (11a) Yellow crystals; yield: 0.61 g (80%); mp 231–233 °C. IR (KBr): 3347, 3110, 2928, 2850, 1689, 1599, 1546, 1502, 1448, 1265, 1194 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.94–1.01 (m, 2 H), 1.11–1.17 (m, 3 H), 1.39–1.42 (m, 1 H), 1.56–1.59 (m, 2 H), 1.86–1.88 (m, 2 H), 2.79–2.81 (m, 1 H), 4.04 (s, 3 H), 5.46 (br s, 1 H), 6.99 (d, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.9 Hz, 1 H), 7.50 (d, J = 6.8 Hz, 1 H), 7.51 (t, J = 8.5 Hz, 1 H), 7.62 (d, J = 7.9 Hz, 1 H), 7.72 (t, J = 7.9 Hz, 1 H), 7.79 (d, J = 7.9 Hz, 1 H), 8.13 (d, J = 6.8 Hz, 1 H), 8.14 (t, J = 8.5 Hz, 1 H), 8.27 (d, J = 8.6 Hz, 1 H), 8.94 (d, J = 8.6 Hz, 1 H), 9.54 (d, J = 7.5 Hz, 1 H). 13C NMR (125.7 MHz, CDCl3): δ = 25.1 (2 CH2), 25.7 (CH), 33.8 (2 CH2), 51.4 (MeO), 57.9 (CH), 101.8 (C), 112.8 (CH), 113.8 (C), 122.5 (C), 123.1 (CH), 123.2 (CH), 124.8 (C), 126.0 (CH), 126.3 (CH), 126.4 (CH), 126.6 (CH), 126.8 (CH), 127.1 (CH), 127.5 (C), 129.5 (CH), 129.9 (CH), 131.3 (C), 135.6 (CH), 141.7 (C), 147.5 (C), 152.1 (C), 166.9 (C=O). MS (EI): m/z (%) = 449 (100) [M]+, 416 (42), 374 (50), 346 (30), 308 (55), 279 (30), 240 (32), 208 (30), 167 (20), 128 (50), 83 (40), 55 (45). Anal. Calcd for C29H27N3O2 (449.54): C, 77.48; H, 6.05; N, 9.35. Found: C, 78.02; H, 6.11; N, 9.42.

    • For details, see:
    • 12a Farrugia LJ. J. Appl. Crystallogr. 1999; 32: 837
    • 12b Allen FH, Johnson O, Shields GP, Smith BR, Towler M. J. Appl. Crystallogr. 2004; 37: 335
    • 12c Macrae CF, Edgington PR, McCabe P, Pidcock E, Shields GP, Taylor R, Towler M, van der Streek J. J. Appl. Crystallogr. 2006; 39: 453
    • 12d Burnett MN, Johnson CK. ORTEP-III: Oak Ridge Thermal Ellipsoid Plot Program for Crystal Structure Illustrations, Oak Ridge National Laboratory Report ORNL-6895. Oak Ridge National Laboratory; Oak Ridge: 1996
    • 12e Spek AL. J. Appl. Crystallogr. 2003; 36: 7
    • 12f Sheldrick GM. Acta Crystallogr., Sect. A 2008; 64: 112
    • 12g Coppens P, Leiserowitz L, Rabinovich D. Acta Crystallogr. 1965; 18: 1035